Reed Joshua — SEC insider filings

SEC reporting owner CIK 1746541. 17 insider filings on record with FilingPulse; latest filed 2026-10-09.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2021-03-18 to 2026-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Scholar Rock Holding Corp (SRRK)Director8—4 legs · 8,453 sh · $324,5309
Alkermes plc. (ALKS)SVP, Chief Financial Officer3——7
Omega Therapeutics, Inc. (OMGA)Chief Financial Officer4——4
Aldeyra Therapeutics, Inc. (ALDX)Chief Financial Officer2——3

Insider filings — Reed Joshua

FiledFormIssuerReported transactionsSource
2026-10-094Alkermes plc. (ALKS)Option exercise (M): 9,164 · Tax withholding (F): 4,069 @ $40.11 · Option exercise (M): 9,164 (derivative)EDGAR
2026-07-064Scholar Rock Holding Corp (SRRK)Sale (S): 2,105 @ $53.50 · Sale (S): 948 @ $54.28EDGAR
2026-06-084Scholar Rock Holding Corp (SRRK)Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0EDGAR
2026-03-044Alkermes plc. (ALKS)Grant/award (A): 66,430 (derivative) @ $0 · Grant/award (A): 30,854 (derivative) @ $0EDGAR
2025-10-104Alkermes plc. (ALKS)Grant/award (A): 158,743 (derivative) @ $0 · Grant/award (A): 36,656 (derivative) @ $0EDGAR
2025-05-304Scholar Rock Holding Corp (SRRK)Sale (S): 4,900 @ $29.68 · Sale (S): 500 @ $30.04EDGAR
2025-05-234Scholar Rock Holding Corp (SRRK)Grant/award (A): 7,632 @ $0 · Grant/award (A): 9,206 (derivative) @ $0EDGAR
2024-07-014Scholar Rock Holding Corp (SRRK)Grant/award (A): 13,500 @ $0 · Grant/award (A): 18,000 (derivative) @ $0EDGAR
2024-02-094Omega Therapeutics, Inc. (OMGA)Grant/award (A): 110,000 (derivative) @ $0EDGAR
2023-06-224Scholar Rock Holding Corp (SRRK)Grant/award (A): 36,000 (derivative) @ $0EDGAR
2023-03-024Omega Therapeutics, Inc. (OMGA)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2022-10-284Omega Therapeutics, Inc. (OMGA)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2022-06-024Omega Therapeutics, Inc. (OMGA)Grant/award (A): 320,000 (derivative) @ $0EDGAR
2022-05-274Scholar Rock Holding Corp (SRRK)Grant/award (A): 28,000 (derivative) @ $0EDGAR
2022-04-014Aldeyra Therapeutics, Inc. (ALDX)Grant/award (A): 93,322 @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2021-04-144Aldeyra Therapeutics, Inc. (ALDX)Grant/award (A): 150,185 (derivative) @ $0EDGAR
2021-03-184Scholar Rock Holding Corp (SRRK)Grant/award (A): 15,600 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1746541 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs